Compounds and methods for prevention and treatment of her-2/neu associated malignancies
CA 2398102 A1 · Owner: Corixa Corporation · Inventors: Hand-Zimmermann, Susan; Cheever, Martin A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds and compositions for eliciting or enhancing immune reactivity to HER- 2/neu protein are disclosed. The compounds include antigen-presenting cells such as dendritic cells, which may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.